Institutional Ownership
Psyence Biomedical Ltd
CUSIP 74449F118*W EXP 01/25/202PBMWWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
19
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Harraden Circle Investments, LLC | 1.15M | $20.9K |
| 2 | Polar Asset Management Partners Inc. | 733.0K | $13.3K |
| 3 | Mmcap International Inc. Spc | 600.0K | $10.9K |
| 4 | Toronto Dominion Bank | 503.3K | $9.1K |
| 5 | Calamos Advisors LLC | 500.0K | $9.1K |
| 6 | Saba Capital Management, L.P. | 297.8K | $5.4K |
| 7 | Clear Street Group Inc. | 257.2K | $4.7K |
| 8 | Aristeia Capital, L.L.C. | 215.3K | $3.9K |
| 9 | Goldman Sachs Group Inc | 200.1K | $3.6K |
| 10 | Lmr Partners LLP | 200.0K | $3.6K |